{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:10:07Z","timestamp":1778497807514,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Patolog\u00eda"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.patol.2018.04.003","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:54:01Z","timestamp":1529369641000},"page":"20-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Correlation of mRNA-PCA3 urine levels with the new grading system in prostate cancer"],"prefix":"10.1016","volume":"52","author":[{"given":"Natalia","family":"Rodon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Trias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montse","family":"Verd\u00fa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miquel","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep M\u00aa","family":"Banus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Puig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.patol.2018.04.003_bib0155","series-title":"International Agency for Research on Cancer","author":"World Cancer Report 2014","year":"2014"},{"key":"10.1016\/j.patol.2018.04.003_bib0160","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/B978-0-12-387688-1.00007-7","article-title":"Prostate cancer as a model system for genetic diversity in tumors","volume":"112","author":"Squire","year":"2011","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.patol.2018.04.003_bib0165","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1046\/j.1464-4096.2001.02449.x","article-title":"Screening for prostate cancer: evidence and perspectives","volume":"88","author":"Sch\u00f6der","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.patol.2018.04.003_bib0170","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schroder","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patol.2018.04.003_bib0175","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patol.2018.04.003_bib0180","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-Year outcomes after monitoring, surgery or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patol.2018.04.003_bib0185","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1200\/JCO.2013.52.8505","article-title":"Can urinary PCA3 supplement PSA in the early detection of prostate cancer?","volume":"32","author":"Wei","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.patol.2018.04.003_bib0190","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.juro.2008.07.060","article-title":"PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume","volume":"180","author":"Whitman","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.patol.2018.04.003_bib0195","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.juro.2008.01.013","article-title":"PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance","volume":"179","author":"Nakanishi","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.patol.2018.04.003_bib0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13046-015-0127-8","article-title":"PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience","volume":"6","author":"Merola","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.patol.2018.04.003_bib0205","first-page":"150","article-title":"Diagnostic and predictive value of urine PCA3 gene expression for the clinical management of patients with altered prostate-specific antigen","volume":"38","author":"Rodon","year":"2014","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.patol.2018.04.003_bib0210","first-page":"427","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Definition of grading patterns and proposal for a new grading system","volume":"76","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.patol.2018.04.003_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eururo.2015.02.038","article-title":"Future proofing Gleason grading: what to call Gleason 6 prostate cancer?","volume":"68","author":"Loeb","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.patol.2018.04.003_bib0220","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/pros.23142","article-title":"Changes in prostate cancer grading: including a new patient-centric grading system","volume":"5","author":"Kryvenko","year":"2016","journal-title":"Prostate"},{"key":"10.1016\/j.patol.2018.04.003_bib0225","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1373\/clinchem.2005.063289","article-title":"APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer","volume":"52","author":"Groskopf","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.patol.2018.04.003_bib0230","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.acuro.2010.02.019","article-title":"Assessment of the PCA3 test for prostate cancer diagnosis: a systemic review and meta-analysis","volume":"34","author":"Ruiz-Arag\u00f3n","year":"2010","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.patol.2018.04.003_bib0235","first-page":"255A","article-title":"PCA3 gene in prostate diagnosis: improving biopsy efficiency and predicting tumor grade and extension","volume":"27","author":"Rodon","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.patol.2018.04.003_bib0240","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","article-title":"The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma","volume":"29","author":"Epstein","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.patol.2018.04.003_bib0245","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/PAS.0b013e3182556dcd","article-title":"Do adenocarcinomas of the prostate with Gleason score\u22646 have the potential to metastasize to lymph nodes?","volume":"36","author":"Ross","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.patol.2018.04.003_bib0250","unstructured":"Friendly M. Working with categorical data with R and the vcd and vcdExtra packages."},{"key":"10.1016\/j.patol.2018.04.003_bib0255","series-title":"Using R for introductory statistics","author":"Verzani","year":"2004"},{"key":"10.1016\/j.patol.2018.04.003_bib0260","series-title":"R: A language and environment for statistical computing","author":"R Core team","year":"2016"},{"key":"10.1016\/j.patol.2018.04.003_bib0265","doi-asserted-by":"crossref","first-page":"E778","DOI":"10.1111\/j.1464-410X.2012.11645.x","article-title":"Histological chronic prostatitis and high-grade prostate intra-epithelial neoplasia do not influence urinary prostate cancer gene 3 score","volume":"110","author":"De Luca","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.patol.2018.04.003_bib0270","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.eururo.2008.06.071","article-title":"Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy","volume":"54","author":"Haese","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.patol.2018.04.003_bib0275","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.juro.2011.01.075","article-title":"Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions","volume":"185","author":"de la Taille","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.patol.2018.04.003_bib0280","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.juro.2013.12.005","article-title":"Urinary PCA3 as a predictor of prostate cancer in a cohort of 3.073 men undergoing initial prostate biopsy","volume":"191","author":"Chevli","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.patol.2018.04.003_bib0285","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1464-410X.2011.10377.x","article-title":"The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance","volume":"109","author":"van Poppel","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.patol.2018.04.003_bib0290","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrurol.2009.40","article-title":"The use of PCA3 in the diagnosis of prostate cancer","volume":"6","author":"Hessels","year":"2009","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.patol.2018.04.003_bib0295","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.juro.2013.02.018","article-title":"PROGENSA\u00ae PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study","volume":"190","author":"Gittelman","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.patol.2018.04.003_bib0300","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.urology.2017.05.028","article-title":"Prostate cancer antigen 3 score does not predict for adverse pathologic features at radical prostatectomy or for progression-free survival in clinically localized intermediate- and high-risk prostate cancer","volume":"107","author":"Hegde","year":"2017","journal-title":"Urology"}],"container-title":["Revista Espa\u00f1ola de Patolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699885518300382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699885518300382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T19:21:03Z","timestamp":1545420063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699885518300382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1699885518300382"],"URL":"https:\/\/doi.org\/10.1016\/j.patol.2018.04.003","relation":{},"ISSN":["1699-8855"],"issn-type":[{"value":"1699-8855","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation of mRNA-PCA3 urine levels with the new grading system in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Patolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.patol.2018.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Sociedad Espa\u00f1ola de Anatom\u00eda Patol\u00f3gica. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}